PNC Financial Services Group’s AtriCure ATRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$165K Buy
5,891
+1,143
+24% +$32.2K ﹤0.01% 2597
2026
Q1
$135K Sell
4,748
-347
-7% -$11.8K ﹤0.01% 2609
2025
Q4
$202K Sell
5,095
-1,093
-18% -$40.1K ﹤0.01% 2312
2025
Q3
$218K Buy
6,188
+380
+7% +$13.1K ﹤0.01% 2244
2025
Q2
$190K Buy
5,808
+770
+15% +$25K ﹤0.01% 2244
2025
Q1
$163K Sell
5,038
-186
-4% -$6.91K ﹤0.01% 2332
2024
Q4
$160K Sell
5,224
-542
-9% -$17.4K ﹤0.01% 2374
2024
Q3
$162K Buy
5,766
+1,186
+26% +$29.2K ﹤0.01% 2354
2024
Q2
$104K Sell
4,580
-796
-15% -$18.4K ﹤0.01% 2606
2024
Q1
$164K Sell
5,376
-764
-12% -$25.6K ﹤0.01% 2319
2023
Q4
$219K Buy
6,140
+135
+2% +$5.02K ﹤0.01% 2085
2023
Q3
$263K Sell
6,005
-786
-12% -$38.3K ﹤0.01% 1923
2023
Q2
$335K Buy
6,791
+286
+4% +$13.2K ﹤0.01% 1841
2023
Q1
$270K Sell
6,505
-273
-4% -$11.3K ﹤0.01% 1961
2022
Q4
$301K Sell
6,778
-948
-12% -$39.6K ﹤0.01% 1855
2022
Q3
$302K Buy
7,726
+786
+11% +$36K ﹤0.01% 1822
2022
Q2
$284K Buy
6,940
+965
+16% +$45.7K ﹤0.01% 1908
2022
Q1
$392K Buy
5,975
+1,931
+48% +$125K ﹤0.01% 1826
2021
Q4
$281K Sell
4,044
-793
-16% -$57.6K ﹤0.01% 2043
2021
Q3
$335K Buy
4,837
+606
+14% +$46.6K ﹤0.01% 1875
2021
Q2
$336K Sell
4,231
-549
-11% -$39.9K ﹤0.01% 1890
2021
Q1
$313K Buy
4,780
+463
+11% +$28.5K ﹤0.01% 1880
2020
Q4
$240K Sell
4,317
-134
-3% -$5.79K ﹤0.01% 1950
2020
Q3
$178K Sell
4,451
-253
-5% -$10.7K ﹤0.01% 2003
2020
Q2
$212K Sell
4,704
-157
-3% -$6.84K ﹤0.01% 1897
2020
Q1
$163K Sell
4,861
-299
-6% -$10.8K ﹤0.01% 1931
2019
Q4
$168K Sell
5,160
-6,894
-57% -$196K ﹤0.01% 2170
2019
Q3
$301K Buy
12,054
+1,575
+15% +$45K ﹤0.01% 1894
2019
Q2
$313K Buy
10,479
+2,830
+37% +$82.6K ﹤0.01% 1907
2019
Q1
$205K Buy
7,649
+3,318
+77% +$101K ﹤0.01% 2131
2018
Q4
$133K Buy
4,331
+2,373
+121% +$73.9K ﹤0.01% 2296
2018
Q3
$69K Buy
+1,958
New +$62K ﹤0.01% 2808
2016
Q3
Sell
-108
Closed -$2K 3980
2016
Q2
$2K Sell
108
-47
-30% -$716 ﹤0.01% 4129
2016
Q1
$3K Sell
155
-1,336
-90% -$23.5K ﹤0.01% 4014
2015
Q4
$33K Buy
1,491
+188
+14% +$3.87K ﹤0.01% 3034
2015
Q3
$28K Sell
1,303
-326
-20% -$8.15K ﹤0.01% 3190
2015
Q2
$41K Buy
1,629
+235
+17% +$5.25K ﹤0.01% 3137
2015
Q1
$29K Sell
1,394
-31
-2% -$601 ﹤0.01% 3319
2014
Q4
$29K Sell
1,425
-34
-2% -$583 ﹤0.01% 3007
2014
Q3
$21K Buy
1,459
+95
+7% +$1.51K ﹤0.01% 3040
2014
Q2
$25K Buy
1,364
+1,284
+1,605% +$21.4K ﹤0.01% 2849
2014
Q1
$2K Buy
+80
New +$1.64K ﹤0.01% 3452

Other funds holding ATRC

PNC Financial Services Group's ATRC Position: Q2 2026 in Review

PNC Financial Services Group increased its AtriCure (ATRC) stake by 24% in Q2 2026, buying an estimated $32.2K and bringing the position to 5,891 shares worth $165K. The position accounts for ﹤0.01% of the portfolio, ranked #2597.

PNC Financial Services Group first reported a position in ATRC in Q1 2014 and has held it in 42 quarters since. The position peaked at $392K in Q1 2022. 107 funds tracked by Wall St. Rank hold ATRC as of Q2 2026.

  • PNC Financial Services Group held 5,891 shares of AtriCure worth $165K as of Q2 2026.
  • PNC Financial Services Group bought 1,143 AtriCure shares in Q2 2026, an estimated $32.2K.
  • AtriCure made up ﹤0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #2597 holding.
  • PNC Financial Services Group first reported a position in AtriCure in Q1 2014 and has held it in 42 quarters since.
  • PNC Financial Services Group's AtriCure position peaked at $392K in Q1 2022.
  • 107 funds tracked by Wall St. Rank held AtriCure as of Q2 2026.

Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.